Making sense of prostate specific antigen: Improving its predictive value in patients undergoing prostate biopsy

Journal of Urology

Volumn 175, Issue 2, 2006, Pages 489-494

  Nam, Robert K ^a,d   Toi, Ants ^b   Trachtenberg, John ^a   Klotz, Laurence H ^a   Jewett, Michael A S ^a   Emami, Marjan ^a   Sugar, Linda ^b   Sweet, Joan ^b   Pond, Greg R ^a   Narod, Steven A ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d NONE   (Canada)

Author keywords

Prostate; Prostate specific antigen; Prostatic neoplasms; Risk

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DEMOGRAPHY; DIGITAL RECTAL EXAMINATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DIGITAL RECTAL EXAMINATION; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 30344455652     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00159-X     Document Type: Article

References (20)

1. I.M. Thompson, P.J. Goodman, C.M. Tangen, M.S. Lucia, G.J. Miller, L.G. Ford The influence of finasteride on the development of prostate cancer N Engl J Med 349 2003 215
2. T.A. Stamey, M. Caldwell, J.E. McNeal, R. Nolley, M. Hemenez, J. Downs The prostate specific antigen era in the United States is over for prostate cancer what happened in the last 20 years? J Urol 172 2004 1297
3. R.E. Reiter, J.B. deKernion Epidemiology, etiology and prevention of prostate cancer P.C. Walsh A.B. Retik E.D. Vaughan Jr. A.J. Wein 8th ed. Campbell's Urology vol. 4 2002 W. B. Saunders Co Philadelphia 3001 3016 sect. XI, chapt. 85
4. S.A. Narod, A. Dupont, L. Cusan, P. Diamond, J.L. Gomez, R. Suburu The impact of family history on early detection of prostate cancer Nat Med 1 1995 99
5. W.J. Catalona, P.C. Southwick, K.M. Slawin, A.W. Partin, M.K. Brawer, R.C. Flanigan Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging Urology 56 2000 255
6. R.K. Nam, A. Toi, J. Trachtenberg, M.A. Jewett, L. Klotz, N. Fleshner Variation in patterns of practice in diagnosing screen-detected prostate cancer BJU Int 94 2004 1239
7. W.J. Catalona, D.S. Smith, D.K. Ornstein Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements JAMA 277 1997 1452
8. M.J. Barry, F.J. Fowler Jr., M.P. O'Leary, R.C. Bruskewitz, H.L. Holtgrewe, W.K. Mebust The Measurement Committee of the American Urological Association The American Urological Association symptom index for benign prostatic hyperplasia J. Urol. 148 1992 1549
9. M.K. Terris Ultrasonography and biopsy of the prostate P.C. Walsh A.B. Retik E.D. Vaughan Jr. A.J. Wein 8th ed. Campbell's Urology vol. 4 2002 W. B. Saunders Co Philadelphia 3038 3054 sect. XI, chapt. 87
10. B. Djavan, V. Ravery, A. Zlotta, P. Dobronski, M. Dobrovits, M. Fakhari Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4 when should we stop? J Urol 166 2001 1679
11. L. Breiman, J.H. Friedman, R.A. Olshen, C.J. Stone Classification and Regression Trees 1984 Wadsworth International Belmont, California
12. W.J. Catalona, D.S. Smith, T.L. Ratliff, K.M. Dodds, D.E. Coplen, J.J.J. Yuan Measurement of prostate-specific antigen in serum as a screening test for prostate cancer New Engl J Med 324 1991 1156
13. G.J. Matthews, J. Motta, J.A. Fracehia The accuracy of transrectal ultrasound prostate volume estimation clinical correlations J Clin Ultrasound 24 1996 501
14. T. Ohigashi, K. Kanao, E. Kikuchi, K. Nakagawa, J. Nakashima, K. Marumo Prostate specific antigen adjusted for transition zone epithelial volume the powerful predictor for the detection of prostate cancer on repeat biopsy J Urol 173 2005 1541
15. E. Lopez-Corona, M. Ohori, P.T. Scardino, V.E. Reuter, M. Gonen, M.W. Kattan A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session J Urol 170 2003 1184
16. R.K. Nam, W.W. Zhang, J. Trachtenberg, E.P. Diamandis, A. Toi, M. Emami Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection J Clin Oncol 21 2003 2312
17. A.W. Partin, M.K. Brawer, G. Bartsch, W. Horninger, S.S. Taneja, H. Lepor Complexed prostate specific antigen improves specificity for prostate cancer detection results of a prospective multicenter clinical trial J Urol 170 2003 1787
18. P.A. Kupelian, V.A. Kupelian, J.S. Witte, R. Macklis, E.A. Klein Family history of prostate cancer in patients with localized prostate cancer an independent predictor of treatment outcome J Clin Oncol 15 1997 1478
19. E. Giovannucci, M.J. Stampfer, K. Krithivas, M. Brown, A. Brufsky, J. Talcott The CAG repeat within the androgen receptor gene and its relationship to prostate cancer Proc Natl Acad Sci USA 94 1997 3320
20. L. Wang, S.K. McDonnell, D.A. Elkins, S.L. Slager, E. Christensen, A.F. Marks Analysis of the RNASEL gene in familial and sporadic prostate cancer Am J Hum Genet 71 2002 116